Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

NCT05797246 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

21

Enrollment

NIH

Sponsor class

Conditions

Respiratory Tract Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Neoplasms, Squamous Cell
Tumor Virus Infections
Infections
Virus Diseases
DNA Virus Infections
Pathologic Processes
Disease Attributes
Recurrence
Papilloma
Respiratory Tract Infections
Papillomavirus Infections

Interventions

DRUG: Bevacizumab

Sponsor

National Cancer Institute (NCI)